amobarbital has been researched along with Seizures, Febrile in 2 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
Seizures, Febrile: Seizures that occur during a febrile episode. It is a common condition, affecting 2-5% of children aged 3 months to five years. An autosomal dominant pattern of inheritance has been identified in some families. The majority are simple febrile seizures (generally defined as generalized onset, single seizures with a duration of less than 30 minutes). Complex febrile seizures are characterized by focal onset, duration greater than 30 minutes, and/or more than one seizure in a 24 hour period. The likelihood of developing epilepsy (i.e., a nonfebrile seizure disorder) following simple febrile seizures is low. Complex febrile seizures are associated with a moderately increased incidence of epilepsy. (From Menkes, Textbook of Child Neurology, 5th ed, p784)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fifty-five percent had a history of febrile seizures." | 2.69 | Presurgical evaluation and surgical outcome of temporal lobe epilepsy. ( Asconape, J; Azzarelli, B; Garg, B; Hutchins, GD; Markand, O; Park, HM; Patel, H; Salanova, V; Smith, R; Worth, R, 1999) |
| "MRI-HS correlated with a history of febrile seizures and pathologically demonstrated hippocampal sclerosis." | 1.30 | FDG-PET and MRI in temporal lobe epilepsy: relationship to febrile seizures, hippocampal sclerosis and outcome. ( Azzarelli, B; Ghetti, B; Hutchins, G; Markand, O; Park, H; Salanova, V; Smith, R; Wellman, H; Worth, R, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Salanova, V | 2 |
| Markand, O | 2 |
| Worth, R | 2 |
| Smith, R | 2 |
| Wellman, H | 1 |
| Hutchins, G | 1 |
| Park, H | 1 |
| Ghetti, B | 1 |
| Azzarelli, B | 2 |
| Garg, B | 1 |
| Patel, H | 1 |
| Asconape, J | 1 |
| Park, HM | 1 |
| Hutchins, GD | 1 |
1 trial available for amobarbital and Seizures, Febrile
| Article | Year |
|---|---|
Presurgical evaluation and surgical outcome of temporal lobe epilepsy.
Topics: Adolescent; Adult; Age Factors; Amobarbital; Brain Diseases; Brain Neoplasms; Child; Electroencephal | 1999 |
1 other study available for amobarbital and Seizures, Febrile
| Article | Year |
|---|---|
FDG-PET and MRI in temporal lobe epilepsy: relationship to febrile seizures, hippocampal sclerosis and outcome.
Topics: Adolescent; Adult; Amobarbital; Atrophy; Carotid Artery, Internal; Child; Electroencephalography; Ep | 1998 |